A relative value estimate based on recent M&A deals similar to Pfizer. In the interest of time, Archie does not want you to identify suitable mega M&A deals in the drugs sector that could be comparable precedent transactions. Instead, he wants you to use an LTM EBITDA multiple range of $15$ to $20$x and an LTM P$/$E multiple range of $18$ to $25$x to value Pfizer.